CD46 and myeloid sarcoma: The CD3/CD46 cross-linking would induce expression of IL-1beta and IL-17A in MS patients’ T cells, suggesting a potential mechanism of virus-induced neuroinflammation that could be involved in MS disease pathogenesis.